Drug profile

The FDA adverse-event record for Bovine Viral Diarrhea Virus, 53637, Bvd2Mlv-D; Bovine Viral Diarrhea Virus, Nadl

22 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Bovine Viral Diarrhea Virus, 53637, Bvd2Mlv-D; Bovine Viral Diarrhea Virus, Nadl. See the species affected, top reactions, and outcomes below.

22
adverse-event reports
86.4%
death-coded share
Cattle
most-reported species
20
Lack of efficacy (bacteria) - NOS - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
22
Total Reports
19
Deaths Reported
86.4%
Death Rate

Active Ingredients

Bovine Viral Diarrhea Virus, 53637, Bvd2Mlv-D; Bovine Viral Diarrhea Virus, Nadl

Administration Routes

SubcutaneousIntramuscularUnknown

Species Affected

Cattle 20
Unknown 2

Most Affected Breeds

Cattle (other) 15
Cattle (unknown) 2
Aberdeen Angus 2
Unknown 2
Crossbred Bovine/Cattle 1

Most Reported Reactions

Lack of efficacy (bacteria) - NOS 20
Death 10
Lack of efficacy - NOS 6
DEATH-TREATMENT FAILURE 5
CULTURE/TITER DATA ABNORMAL 5
Caps, Abnormal 2
PR-LUNG(S), LESION(S) 2
Death by euthanasia 1
Copper deficiency signs 1
Selenium deficiency syndrome 1
Increased mortality rate 1
Insert, Abnormal 1

Outcome Breakdown

Died
18 (47.4%)
Outcome Unknown
9 (23.7%)
Ongoing
7 (18.4%)
Recovered/Normal
2 (5.3%)
Euthanized
2 (5.3%)

Bovine Viral Diarrhea Virus, 53637, Bvd2Mlv-D; Bovine Viral Diarrhea Virus, Nadl Adverse Event Insights

22 reports name Bovine Viral Diarrhea Virus, 53637, Bvd2Mlv-D; Bovine Viral Diarrhea Virus, Nadl; 19 recorded a death outcome (86.4% of reported events, not a population-level mortality rate). Active ingredient: Bovine Viral Diarrhea Virus, 53637, Bvd2Mlv-D; Bovine Viral Diarrhea Virus, Nadl. Administration routes: Subcutaneous, Intramuscular, Unknown.

By species: Cattle (20 reports), Unknown (2 reports). By breed: Cattle (other) (15), Cattle (unknown) (2), Aberdeen Angus (2).

Leading clinical signs: Lack of efficacy (bacteria) - NOS (20), Death (10), Lack of efficacy - NOS (6), DEATH-TREATMENT FAILURE (5). Outcome, 38 coded reports: Died leads at 47.4%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.